ZA949302B - Prolyl endopeptidase inhibitors. - Google Patents

Prolyl endopeptidase inhibitors.

Info

Publication number
ZA949302B
ZA949302B ZA949302A ZA949302A ZA949302B ZA 949302 B ZA949302 B ZA 949302B ZA 949302 A ZA949302 A ZA 949302A ZA 949302 A ZA949302 A ZA 949302A ZA 949302 B ZA949302 B ZA 949302B
Authority
ZA
South Africa
Prior art keywords
prolyl endopeptidase
endopeptidase inhibitors
compounds
formula
present
Prior art date
Application number
ZA949302A
Other languages
English (en)
Inventor
Norton P Peet
Joseph P Burkhart
Shujaath Mehdi
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of ZA949302B publication Critical patent/ZA949302B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D277/06—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA949302A 1993-12-02 1994-11-23 Prolyl endopeptidase inhibitors. ZA949302B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16110693A 1993-12-02 1993-12-02

Publications (1)

Publication Number Publication Date
ZA949302B true ZA949302B (en) 1995-08-07

Family

ID=22579844

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA949302A ZA949302B (en) 1993-12-02 1994-11-23 Prolyl endopeptidase inhibitors.

Country Status (19)

Country Link
US (1) US5661167A (xx)
EP (1) EP0731788B1 (xx)
JP (1) JPH09506090A (xx)
KR (1) KR100341982B1 (xx)
CN (1) CN1136806A (xx)
AT (1) ATE223894T1 (xx)
AU (1) AU684861B2 (xx)
CA (1) CA2177821C (xx)
DE (1) DE69431359T2 (xx)
DK (1) DK0731788T3 (xx)
ES (1) ES2179093T3 (xx)
HU (1) HUT74687A (xx)
IL (1) IL111775A (xx)
NO (1) NO962238L (xx)
NZ (1) NZ276600A (xx)
PT (1) PT731788E (xx)
TW (1) TW280818B (xx)
WO (1) WO1995015310A1 (xx)
ZA (1) ZA949302B (xx)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5859031A (en) 1995-06-07 1999-01-12 Gpi Nil Holdings, Inc. Small molecule inhibitors of rotamase enzyme activity
EP1620091B1 (en) 2003-05-05 2010-03-31 Probiodrug AG Inhibitors of glutaminyl cyclase
WO2005049027A2 (en) 2003-11-03 2005-06-02 Probiodrug Ag Combinations useful for the treatment of neuronal disorders
EP1824846A2 (en) 2003-11-03 2007-08-29 Probiodrug AG Novel compounds for the treatment of neurological disorders
WO2005075436A2 (en) 2004-02-05 2005-08-18 Probiodrug Ag Novel inhibitors of glutaminyl cyclase
EP2089383B1 (en) 2006-11-09 2015-09-16 Probiodrug AG 3-hydr0xy-1,5-dihydr0-pyrr0l-2-one derivatives as inhibitors of glutaminyl cyclase for the treatment of ulcer, cancer and other diseases
ATE554085T1 (de) 2006-11-30 2012-05-15 Probiodrug Ag Neue inhibitoren von glutaminylcyclase
CA2679446C (en) 2007-03-01 2016-05-17 Probiodrug Ag New use of glutaminyl cyclase inhibitors
EP2142514B1 (en) 2007-04-18 2014-12-24 Probiodrug AG Thiourea derivatives as glutaminyl cyclase inhibitors
US8524654B2 (en) * 2007-05-21 2013-09-03 The Uab Research Foundation Prolyl endopeptidase inhibitors for reducing or preventing neutrophilic inflammation
CA2772488C (en) 2009-09-11 2018-04-17 Probiodrug Ag Heterocyclic derivatives as inhibitors of glutaminyl cyclase
ES2586231T3 (es) 2010-03-03 2016-10-13 Probiodrug Ag Inhibidores de glutaminil ciclasa
EP2545047B9 (en) 2010-03-10 2015-06-10 Probiodrug AG Heterocyclic inhibitors of glutaminyl cyclase (qc, ec 2.3.2.5)
US8541596B2 (en) 2010-04-21 2013-09-24 Probiodrug Ag Inhibitors
ES2570167T3 (es) 2011-03-16 2016-05-17 Probiodrug Ag Derivados de benzimidazol como inhibidores de glutaminil ciclasa
US9771786B2 (en) 2014-01-28 2017-09-26 Spirit Global Energy Solutions, Inc. Down-hole gas and solids separator utilized in production hydrocarbons
EP3461819B1 (en) 2017-09-29 2020-05-27 Probiodrug AG Inhibitors of glutaminyl cyclase

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4518528A (en) * 1983-05-19 1985-05-21 Rasnick David W α Amino fluoro ketones
CA1341029C (en) * 1985-02-04 2000-06-20 Michael Kolb Peptidase inhibitors
DE3712365A1 (de) * 1987-04-11 1988-10-27 Hoechst Ag Neue 2-acylpyrrolidin-derivate, verfahren zu ihrer herstellung, sie enthaltende mittel sowie deren verwendung
US4855303A (en) * 1987-07-01 1989-08-08 Pfizer Inc. Fluorine containing renin inhibitors
JPH0662591B2 (ja) * 1988-12-14 1994-08-17 株式会社ヤクルト本社 新規なチオプロリン誘導体
EP0419683A4 (en) * 1989-04-13 1992-03-11 Japan Tobacco Inc. New amino acid derivatives having prolylendopeptidase inhibitor activity

Also Published As

Publication number Publication date
DE69431359D1 (de) 2002-10-17
AU684861B2 (en) 1998-01-08
ES2179093T3 (es) 2003-01-16
WO1995015310A1 (en) 1995-06-08
IL111775A (en) 1998-06-15
PT731788E (pt) 2003-01-31
CA2177821A1 (en) 1995-06-08
JPH09506090A (ja) 1997-06-17
EP0731788A1 (en) 1996-09-18
IL111775A0 (en) 1995-01-24
DE69431359T2 (de) 2003-07-31
NO962238D0 (no) 1996-05-31
HUT74687A (en) 1997-01-28
NZ276600A (en) 1997-09-22
EP0731788B1 (en) 2002-09-11
HU9601472D0 (en) 1996-07-29
NO962238L (no) 1996-05-31
KR100341982B1 (ko) 2002-11-30
DK0731788T3 (da) 2003-01-20
AU1091795A (en) 1995-06-19
CN1136806A (zh) 1996-11-27
CA2177821C (en) 2000-03-28
TW280818B (xx) 1996-07-11
ATE223894T1 (de) 2002-09-15
US5661167A (en) 1997-08-26

Similar Documents

Publication Publication Date Title
TW280818B (xx)
BG103485A (en) Ketobanzamides as calpain inhibitors
ATE172968T1 (de) Substituierte azadioxacycloalkene und ihre verwendung als fungizide
MY112413A (en) Substituted heterocyclic carboxamides, their preparation and their use as pharmaceuticals
CA2107105A1 (en) Heterocyclic-cyclic amine derivatives
TW263499B (xx)
BG101110A (en) Substituted pyrimidine compounds and their application
MX9604367A (es) Hidroxipiridinonas novedosas.
MX9804588A (es) Uso de composiciones que comprenden blanqueador de halogeno para suavidad mejorada a la piel.
BG101867A (en) Benzothiazenedioxides as endothelin antagonists
IL117209A (en) 1-aryl-2-acylamino-ethane compounds and pharmaceutical compositions containing them
MY120550A (en) Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-ols, processes for preparing them and their use as pharmaceutical compositions.
BR9408244A (pt) Derivados de azabiciclo[3.2.0]heptano N-substituídos
GR3029590T3 (en) Crystalline, polymorphic form of (s,s,s)-n-(1- 2-carboxy-3-(n?2 -mesyllysylamino)propyl]-1-cyclopentylcarbonyl)tyrosine
CA2032303A1 (en) Inhibitors of retroviral proteases
PL322969A1 (en) Substituted phenylamidines, pharmaceutic compositions containing theses compounds and method of obtaining them
UA39136C2 (uk) Фармацевтична композиція, яка має активність, що зменшує патологічну гіперактивність еозинофільних гранулоцитів, та похідні ксантину
PL312966A1 (en) Derivatives of thiocarbamoil
NO952926L (no) Fremgangsmåte for fremstilling av C-substituerte dietylentriaminer
GR3029453T3 (en) NOVEL PROCESSES AND INTERMEDIATE COMPOUNDS FOR THE PREPARATION OF PLATELET CLYCOPROTEIN IIb/IIIa INHIBITORS